Updates on Cefiderocol: Activity, Efficacy, and Resistance Mechanisms
Author Information
Author(s): Bianco Gabriele, Boattini Matteo, Cricca Monica, Diella Lucia, Gatti Milo, Rossi Luca, Bartoletti Michele, Sambri Vittorio, Signoretto Caterina, Fonnesu Rossella, Comini Sara, Gaibani Paolo, Dragoi Cristina Manuela, Dumitrescu Ion-Bogdan, Nicolae Alina Crenguța
Primary Institution: University of Salento
Conclusion
Cefiderocol is a promising antibiotic for treating infections caused by multidrug-resistant Gram-negative bacteria, but resistance is emerging.
Supporting Evidence
- Cefiderocol is effective against most strains of Enterobacterales, P. aeruginosa, S. maltophilia, and A. baumannii.
- Resistance to cefiderocol has been reported in certain cohorts, highlighting the need for ongoing surveillance.
- The unique 'Trojan horse' mechanism of cefiderocol allows it to bypass many resistance strategies used by bacteria.
- Clinical studies show cefiderocol's effectiveness in treating infections caused by multidrug-resistant Gram-negative bacteria.
Takeaway
Cefiderocol is a new antibiotic that helps fight tough bacteria, but some bacteria are starting to resist it.
Methodology
This review discusses the mechanism of action, resistance mechanisms, pharmacokinetic/pharmacodynamic properties, and efficacy data of cefiderocol.
Limitations
The emergence of cefiderocol-resistant strains and the need for new strategies to preserve its effectiveness are significant concerns.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website